“Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial”, J of Skin, vol. 4, no. 6, p. s97, Oct. 2020, doi: 10.25251/skin.4.supp.97.